Cited by 655Medication Adherence and ComplianceDiabetes Management and EducationDiabetes Management and Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

Open access

Peyrot, M., Barnett, A. H., Meneghini, L. F., Schumm‐Draeger, P.‐M.·2012·Diabetic Medicine

DOI 10.1111/j.1464-5491.2012.03605.xPMC PMC3433794

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: To examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens. METHODS: Internet survey of 1250 physicians (600 specialists, 650 primary care physicians) who treat patients with diabetes and telephone survey of 1530 insulin-treated patients (180 with Type 1 diabetes, 1350 with Type 2 diabetes) in China, France, Japan, Germany, Spain, Turkey, the UK or the USA. RESULTS: One third (33.2%) of patients reported insulin omission/non-adherence at least 1 day in the last month, with an average of 3.3 days. Three quarters (72.5%) of physicians report that their typical patient does not take their insulin as prescribed, with a mean of 4.3 days per month of basal insulin omission/non-adherence and 5.7 days per month of prandial insulin omission/non-adherence. Patients and providers indicated the same five most common reasons for insulin omission/non-adherence: too busy; travelling; skipped meals; stress/emotional problems; public embarrassment. Physicians reported low patient success at initiating insulin in a timely fashion and adjusting insulin doses. Most physicians report that many insulin-treated patients do not have adequate glucose control (87.6%) and that they would treat more aggressively if not for concern about hypoglycaemia (75.5%). Although a majority of patients (and physicians) regard insulin treatment as restrictive, more patients see insulin treatment as having positive than negative impacts on their lives. CONCLUSIONS: Glucose control is inadequate among insulin-treated patients, in part attributable to insulin omission/non-adherence and lack of dose adjustment. There is a need for insulin regimens that are less restrictive and burdensome with lower risk of hypoglycaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2012.03605.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

FIGURE 1 Physician report: patient success with insulin treatment tasks (n = 1250)*†. *Percentage of physicians reporting that their patients are very successful (vs. somewhat successful, not very successful, not at all successful, ‘don’t know’). †Specialists and primary care physicians not significantly different for any measureCC BY · PubMed Central

FIGURE 2 Patient reports: impact of insulin treatment on life domains in patients with Type 1 (non-hatched) and Type 2 (hatched) diabetes mellitus (n = 1530). *Positive and negative responses differ significantly (P < 0.05); †reports from patients with Type 1 and Type 2 diabetes differ significantly (P < 0.05).CC BY · PubMed Central

FIGURE 3 Physician beliefs about insulin treatment (n = 1250). *Strongly agree or somewhat agree (vs. strongly disagree, somewhat disagree, neither, ‘don’t know’); †strongly agree or somewhat agree (vs. strongly disagree, somewhat disagree)CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoek, F. J., Matthews, D. R., & Skovlund, S. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01644.x · Cited by 931
Self-citation
Resistance to Insulin Therapy Among Patients and Providers
Peyrot, M. F., Rubin, R. R., Lauritzen, T., Skovlund, S. E., Snoek, F. J., Matthews, D. R., Landgraf, R., Kleinebreil, L., & Panel, O. B. O. T. I. D. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2673 · Cited by 784
Self-citation
Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus
Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06234-x · Cited by 507
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407
Self-citation
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus
Rubin, R. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.04.012 · Cited by 403
Psychological insulin resistance: patient beliefs and implications for diabetes management
Brod, M. I., Kongsø, J. H., Alolga, S. L., & Christensen, T. L. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9419-1 · Cited by 238
Insulin therapy for type 2 diabetes.
Swinnen, S. G., Hoekstra, J. B., & DeVries, J. H. (2009) · Diabetes Care · doi:10.2337/dc09-s318 · Cited by 181
Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers
Nakar, S., Yitzhaki, G., Rosenberg, R., & Vinker, S. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.02.004 · Cited by 159

Show all 22 references

Sorted by citations

Items 301–400 of 655

Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
MacIsaac, R. J. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00863-5 · Cited by 11
Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A1chieve study
Belhadj, M., Dahaoui, A., Jamoussi, H., & Farouqi, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(13)70014-7 · Cited by 11
Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration
Strain, W. D., Cos, X., & Prünte, C. F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.01.013 · Cited by 13
Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: What should be the targets for future research?
Sultan, S., El-Hourani, M., Rondeau, É., & Garnier, N. B. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s177624 · Cited by 11
Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
Aleppo, G., Parkin, C. G., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., Umpierrez, G. E., Forlenza, G. P., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0196 · Cited by 11
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 u/ml, and insulin glulisine (basal-bolus therapy)
Kawaguchi, Y., Sawa, J., Hamai, C., Nishimura, Y., & Kumeda, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13038 · Cited by 10
Insulin Adherence in Adolescents with Type 1 Diabetes Mellitus
Dabas, H., Sarin, J., & Madhu, S. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_294_22 · Cited by 12
Factors associated with psychological insulin resistance among patients with type 2 diabetes in China
Zhang, S., Zhang, X., Wang, H., Fan, W., Ma, X., Song, S., & Zhang, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1368132 · Cited by 10
ShotBlocker versus vibration device: Which technique reduces pain and increases satisfaction in insulin injection among type 2 diabetes: A randomized controlled trial
Abdulyemmah, A. D., & Majeed, H. M. (2025) · Journal of Integrative Nursing · doi:10.4103/jin.jin_29_25 · Cited by 10
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice
Aldasouqi, S. A., Mora, S., Bhalla, G., Kakumanu, N., Corser, W. D., Abela, G. S., Dlewati, M. M., Estrada, K., Almounajed, A., Tabbaa, T., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1528437 · Cited by 10
Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
Kalirai, S., Ivanova, J. I., Perez‐Nieves, M., Stephenson, J. J., Hadjiyianni, I., Grabner, M., Pollom, R. D., Geremakis, C. M., Reed, B. L., & Fisher, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s237948 · Cited by 9
Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study
Colin, I. M., Alexandre, K., Bruhwyler, J., Scheen, A. J., & Verhaegen, A. A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00866-2 · Cited by 10
Key factors for overcoming psychological insulin resistance: A qualitative study in Japanese people with type 2 diabetes
OKAZAKI, K., Takahashi, N., Shingaki, T., Perez‐Nieves, M., & Stuckey, H. L. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.009 · Cited by 11
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges
Ekanayake, P. S., & Edelman, S. V. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15059 · Cited by 10
Risk perceptions of patients with type 2 diabetes mellitus regarding insulin therapy and diabetes complications: A cross‐sectional study
Sağlam, F. S., & Bektaş, H. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16720 · Cited by 10
Engineering synthetically modified insulin for glucose-responsive diabetes therapy
Webber, M. J., Anderson, D. G., & Langer, R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1071187 · Cited by 10
Diabetes Attitude Scale: Validation in Type-2 Diabetes Patients in Multiple Centers in China
Lou, Q., Chen, Y., Guo, X., Li, Y., Chen, T., Chun, W., Shen, L., Sun, Z., Zhao, F., Dai, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096473 · Cited by 10
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP ‐1 analogue versus progression to basal‐bolus therapy
Hirsch, I. B., Buse, J. B., Leahy, J. L., McGill, J. B., Peters, A. L., Rodbard, H. W., Rubin, R. R., Skyler, J. S., Verderese, C. A., & Riddle, M. C. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12136 · Cited by 10
Comparison between adherence assessments and blood glucose monitoring measures to predict glycemic control in adults with type 1 diabetes: a cross-sectional study
Teló, G. H., de Souza, M. S., Andrade, T. S., & Schaan, B. D. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0162-4 · Cited by 10
Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes
Pohlmeier, H., Berard, L., Brulle-Wohlhueter, C., Wu, J., Dahmen, R., NOWOTNY, I. K., & Klonoff, D. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816668877 · Cited by 10
Moderating the relationship between diabetes distress and mastery: the role of depression and empowerment
McGuigan, K., Hill, A., COATES, V. E., O’Kane, M., Thompson, D. R., Ski, C. F., & McCay, D. (2021) · Psychology Health & Medicine · doi:10.1080/13548506.2021.1894343 · Cited by 10
Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective
Mohan, V., Mukherjee, J. J., Das, A. K., Seshadri, K., & Dasgupta, A. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100103 · Cited by 10
A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients
Ampudia‐Blasco, F. J., Galán, M., & Brod, M. I. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.03.008 · Cited by 10
Patient preferences for the treatment of type 2 diabetes in Australia: a discrete choice experiment
Ahmad, A., Khan, M. U., & Aslani, P. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00962-5 · Cited by 8
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications
Ingrasciotta, Y., Vitturi, G., & Trifirò, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072113 · Cited by 10
Perspectives and Preferences of People with Type 2 Diabetes for the Attributes of Weekly Insulin
Gelsey, F. T., Schapiro, D., Kosa, K., Vass, C., Perez‐Nieves, M., Pierce, A., Poon, J. L., DiBenedetti, D. B., & Mansfield, C. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01652-0 · Cited by 10
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U‐100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring
Kawaguchi, Y., Hajika, Y., Rinka, M., Masumoto, K., Sawa, J., Hamazaki, K., & Kumeda, Y. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14151 · Cited by 12
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
Onishi, Y., Yamada, K., Zacho, J., Ekelund, J., & Iwamoto, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12569 · Cited by 9
The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool
Hoskins, N., Tikkanen, C. K., & Pedersen‐Bjergaard, U. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1269774 · Cited by 9
Insulin initiation status of primary care physicians in Turkey, barriers to insulin initiation and knowledge levels about insulin therapy: A multicenter cross-sectional study
Ateş, E. A., Set, T., Sağlam, Z. A., Tekın, N., Eray, İ. K., Yavuz, E., Şahin, M. K., Selçuk, E. B., ÇADIRCI, D., & Çubukçu, M. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.05.003 · Cited by 9
Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus
Valencia, W. M., Florez, H. J., & Palacio, A. M. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00706-4 · Cited by 9
Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
Russel-Szymczyk, M., Valov, V., Savova, A., & Manova, M. M. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0460-6 · Cited by 9
A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy
Guzman, S. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0024 · Cited by 9
Synthesis and Characterization of Phenylboronic Acid-Modified Insulin With Glucose-Dependent Solubility
Lin, N.-P., Zheng, N., Purushottam, L., Zhang, Y. W., & Chou, D. H. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.859133 · Cited by 9
Dosing Irregularities and Self-Treated Hypoglycemia in Type 2 Diabetes: Results from the Canadian Cohort of an International Survey of Patients and Healthcare Professionals
Leiter, L. A., Boras, D., & Woo, V. C. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.085 · Cited by 9
Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes: a randomized, 26-week, treat-to-target trial
Kadowaki, T., Jinnouchi, H., Kaku, K., Hersløv, M. L., Hyllested-Winge, J. L., & Nakamura, S. (2016) · Diabetology International · doi:10.1007/s13340-016-0284-9 · Cited by 9
Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
Nabrdalik, K., Kwiendacz, H., Sawczyn, T., Tomasik, A. R., Kukla, M., Masierek, M., & Gumprecht, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6536178 · Cited by 9
A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs
Yi, Y., Li, Y., Hou, A., Ge, Y., Xu, Y., Xiong, G., Yang, X., Acevedo, S., Shi, L., & Xu, H. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0409-1 · Cited by 9
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
Mora, P. F., SUTTON, D. R., Gore, A., Baliga, B. S., Goldfaden, R. F., NIKKEL, C. C., Sink, J. H., & ADAMS-HUET, B. A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001832 · Cited by 9
Perceptions of Insulin Treatment Among African Americans With Uncontrolled Type 2 Diabetes
Bockwoldt, D., Staffileno, B. A., Coke, L. A., & Quinn, L. T. (2014) · Journal of Transcultural Nursing · doi:10.1177/1043659614543477 · Cited by 9
Strategies for implementing effective mealtime insulin therapy in type 2 diabetes
Peyrot, M. F., Bailey, T. S., Childs, B. P., & Reach, G. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1440200 · Cited by 9
Self-citation
Using Oscillation to Improve the Insertion Depth and Consistency of Hollow Microneedles for Transdermal Insulin Delivery with Mechanistic Insights
Smith, F. N. C., Kotowska, A. M., Fiedler, B., Cerny, E., Cheung, K., Rutland, C. S., Chowdhury, F., Segal, J. I., Rawson, F. J., & Marlow, M. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00942 · Cited by 8
Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus
Naggar, N. E., & Kalra, S. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0418-2 · Cited by 8
Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes
Yacoub, T. G. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1389601 · Cited by 7
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases – Recommendations from the taskforce of the guideline workshop
Gavin, J. R., Rodbard, H. W., Battelino, T., Brosius, F. C., Ceriello, A., Cosentino, F., Giorgino, F., Green, J., Ji, L., Kellerer, M., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111666 · Cited by 11
Insulin degludec is a new ultra-long-acting insulin analogue
Dedov, I. I., & Shestakova, M. V. (2014) · Diabetes Mellitus · doi:10.14341/dm2014291-104 · Cited by 8
Acuidade visual no manejo do diabetes mellitus: preparo da dose de insulina
Carvalho, G. C. N., de Freitas, R. W. J. F., de Araújo, M. F. M., Zanetti, M. L., & Damasceno, M. M. C. (2017) · Acta Paulista de Enfermagem · doi:10.1590/1982-0194201700005 · Cited by 8
Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project
Karamat, M. A., Dar, S., Bellary, S., & Tahrani, A. A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0400-x · Cited by 8
Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice
Dağdelen, S., Deyneli, O., Dınççağ, N., ILKOVA, H. M., SİVA, Z. O., Yetkin, İ., & Yilmaz, T. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.663222 · Cited by 8
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US
Shao, H., Alsaleh, A. J. O., DEX, T. A., Lew, E., & Fonseca, V. A. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01300-5 · Cited by 8
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
Ahmann, A. (2015) · Drugs in Context · doi:10.7573/dic.212288 · Cited by 8
Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study
Yavuz, D. G., Bilen, H., Sancak, S., Garip, T., Hekimsoy, Z., Şahin, İ., Yılmaz, M., Aydin, H., Atmaca, A., Sert, M., et al. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s100626 · Cited by 8
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study
Cohen, C. M., Thorsted, B. L., Wolden, M. L., Chodick, G., & Karasik, A. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0297-9 · Cited by 8
Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study
Escalada, J., Bonnet, F., Wu, J., Bonnemaire, M., Gupta, S., Cambron‐Mellott, M. J., Nicholls, C. J., & Müller‐Wieland, D. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01436-5 · Cited by 8
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
Fadini, G. P., Disoteo, O., Candido, R., Bartolo, P. D., Laviola, L., & Consoli, A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01012-2 · Cited by 8
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient-level pooled analysis of EDITION 1, 2 and 3
Bonadonna, R. C., Yale, J., Brulle‐Wohlhueter, C., Boëlle‐Le Corfec, E., Choudhary, P., & Bailey, T. S. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13578 · Cited by 7
Once-weekly insulin icodec versus once-daily long-acting insulins for type 2 diabetes mellitus: Systematic review and meta-analysis
Ribeiro, S. A. G., Pedrotti, M., Hespanhol, L. C., Balieiro, C. C. A., Paqualotto, E., Silva, R. R. E., Gauza, M. D. M., & de Sá, J. R. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100285 · Cited by 7
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6)
Boye, K. S., Poon, J. L., Landó, L. F., Sapin, H., Huh, R., Wang, M., WILLIAMSON, S. E., & Patel, H. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01620-8 · Cited by 7
Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan
Hayashino, Y., Tsuboi, S., Yamamoto, Y., & Ishii, H. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01664-w · Cited by 7
Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
Wolpert, H. A., Rodbard, D., Xue, J., Johnson, J. L., & Dassau, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16249 · Cited by 7
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom
Brod, M. I., Basse, A., Markert, M., & Pfeiffer, K. M. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0636-0 · Cited by 7
Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats
Klotsman, M., Adin, C. A., Anderson, W. H., & Gilor, C. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.661546 · Cited by 8
Utilization and expenditure on long-acting insulin analogs among selected middle-income countries with high patient co-payment levels: Findings and implications for the future
Haque, M., Salequl, I., Rabiu, A. A., Haruna, S. I., Opanga, S. A., Mahmood, K. Z., Farhana, A., & Brian, G. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110720 · Cited by 7
Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin
Shabnam, S., Gillies, C., Davies, M. J., DEX, T. A., Melson, E., Khunti, K., Webb, D. R., Zaccardi, F., & Seidu, S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110888 · Cited by 7
The factors associated with insulin nonpersistence in persons with type 2 diabetes
Yen, F., Wei, J. C., Liu, J., Hsu, C., & Hwu, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108356 · Cited by 7
Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes
Kawaguchi, Y., Miyamoto, S., Hajika, Y., Ashida, N., Masumoto, K., Sawa, J., Hamazaki, K., & Kumeda, Y. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13677 · Cited by 8
The Implications of Health Disparities: A COVID-19 Risk Assessment of the Hispanic Community in El Paso
Cione, C., Vetter, E., Jackson, D., McCarthy, S., & Castañeda, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20020975 · Cited by 7
A novel option for prandial insulin therapy: inhaled insulin
DAILEY, G. E., Ahmad, A., Polsky, S., & Shah, V. N. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1229555 · Cited by 7
Knowledge, attitude and practice of insulin use and its adverse effects in adult diabetic population
Nivethitha, T., Manickavasagam, S., Paramasivam, M., & Sai, G. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20174783 · Cited by 7
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study
Edelman, S. V., Ermakova, A., Xiong, Y., Sieradzan, R., & Taylor, S. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19097 · Cited by 7
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL ( EDITION 1 and EDITION 2 subgroup analysis)
Roussel, R., d'Emden, M. C., Fisher, M., Ampudia‐Blasco, F. J., Stella, P., Bizet, F., Cali, A. M. G., & Wysham, C. H. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13071 · Cited by 6
Content Validity of a Questionnaire Based on the Theory of Planned Behavior to Assess the Psychosocial Determinants of Insulin Adherence
Oliveira, M. K. D. M., Kaizer, U. A. D. O., Jannuzzi, F. F., Gallani, M. C. B. J., Alexandre, N. M. C., Cornélio, M. E., São‐João, T. M., & Rodrigues, R. C. M. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2021.08.007 · Cited by 6
Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France
Riveline, J., Levrat‐Guillen, F., Detournay, B., Vicaut, É., de Pouvourville, G., Emery, C., & Guerci, B. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0171 · Cited by 6
No evidence of increased hypoglycaemia attributed to physical activity with once‐weekly insulin icodec versus once‐daily basal insulin degludec in type 1 diabetes: A post hoc analysis of ONWARDS 6
Sourij, H., Bracken, R. M., Carstensen, L., da Rocha, T. J. C. M., Watt, S. K., & Philis‐Tsimikas, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16265 · Cited by 6
Real world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness
Yang, A., Yu, J., Cheung, J. T. K., Chan, J. C. N., & Chow, E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16386 · Cited by 9
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira)
Morales, J., & Merker, L. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0208-2 · Cited by 6
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study
Nishimura, A., Harashima, S., Fukushige, H., Wang, Y., Liu, Y., Hosoda, K., & Inagaki, N. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0238-7 · Cited by 8
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Mathieu, C., Weisnagel, S. J., Stella, P., Bruhwyler, J., & Alexandre, K. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00749-1 · Cited by 6
Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes
Meade, L. T., & Battise, D. M. (2021) · Clinical Diabetes · doi:10.2337/cd20-0094 · Cited by 6
Attitudes and perceptions of people with diabetes mellitus on patient self-management in diabetes mellitus: a Singapore hospital’s perspective
Ong, C. Y., Lee, W. C. D., Low, S. G., Low, L. L., & Vasanwala, F. F. (2022) · Singapore Medical Journal · doi:10.11622/smedj.2022006 · Cited by 7
Factors associated with non-adherence to insulin in Type 1 and Type 2 diabetes mellitus patients in Western region of Algeria, Tlemcen: a cross-sectional study
Hacene, M. N. B., Zatla, Y. T., Saker, M., Abbou, Z., Youcef, A., Boulenouar, H., Fekir, H., Khaldi, K., Nigassa, N. B., Lounici, A., et al. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.41.172.32972 · Cited by 7
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK
McCrimmon, R. J., PALMER, K. D., Alsaleh, A. J. O., Lew, E., & Puttanna, A. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01267-3 · Cited by 6
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Saleem, S. Z., Fareed, A., Akhtar, S. M. M., Farhat, S., Taha, A. M., & Akilimali, A. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01305-z · Cited by 6
Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens
Oyer, D. S., Niemeyer, M., & Moses, A. C. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2587 · Cited by 6
IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status
Christiansen, J. S., Home, P., & Kumar, A. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1145541 · Cited by 6
Teens' concerns: a national evaluation.
Boehm, K. E., Schondel, C., Marlowe, A. L., & Manke-Mitchell, L. (1999) · PubMed · Cited by 6
Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System
Luo, Y., Ni, W.-J., Ding, B., Xu, X., Ye, L., Ma, J., & Zhu, J. (2019) · Diabetes Therapy · doi:10.1007/s13300-018-0545-7 · Cited by 6
Incidence of hypoglycaemia in the South African population with diabetes: results from the IDMPS Wave 7 study
Kaplan, H., Amod, A., Zyl, F. H. V., Reddy, J., van Tonder, A., Tsymbal, E., & McMaster, A. (2019) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2019.1608053 · Cited by 6
Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
Bae, J. H., Ahn, C. H., Yang, Y., Moon, S. J., Kwak, S. H., Jung, H. S., Park, K. S., & Cho, Y. M. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0274 · Cited by 6
Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes
Gandhi, G. Y., & Mooradian, A. D. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00900-3 · Cited by 11
Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal–bolus therapy in type 1 and type 2 diabetes
Kerlan, V., Gouet, D., Marre, M., & Renard, É. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.04.004 · Cited by 6
Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
Dharmalingam, M. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814552657 · Cited by 6
Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care
Bieszk, N., Grabner, M., Wei, W., Barron, J. O., Quimbo, R. A., Yan, T., Biel, B., & Chu, J. W. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.11.1160 · Cited by 6
Counselling patients for GLP-1 analogue therapy: Comparing GLP-1 analogue with insulin counselling
Kalra, B., & Kalra, S. (2012) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.104315 · Cited by 6
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
Shi, L. X., Li, P. F., & Hou, J. N. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0286-z · Cited by 7
Prescribed Total Daily Insulin Dose and Predictors of Insulin Dose for Adults with Type 2 Diabetes on Multiple Daily Injections of Insulin: A Retrospective Cohort Study
Wright, E. E., Shah, V. N., Miller, E. M., Thach, A., Javadi, P., Davies, S., & Sieradzan, R. (2025) · Diabetology · doi:10.3390/diabetology6020013 · Cited by 5
Effects of a nurse-led diabetes self-management programme for people with type 2 diabetes receiving insulin injection therapy: A randomised controlled trial with qualitative process evaluation
Liang, W., Chow, K. M., Ni, X., Tola, Y. O., & Lo, S. H. S. (2025) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2025.105200 · Cited by 6
Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes
Tannus, L. R. M., Zapelini, R. M., Cabizuca, C. A., Abi-Abib, R. C., Matheus, A. S. D. M., Calassara, P. C., Pozzan, R., & Cobas, R. A. (2022) · Endocrine · doi:10.1007/s12020-022-03137-1 · Cited by 5
The effect of USM-IAM-based counselling vs standard counselling on insulin adherence, FBS and HbA1c among patients with uncontrolled type 2 diabetes mellitus (T2DM): a randomised controlled trial
Zainudin, A. M., Rasool, A. H. G., Yaacob, N. M., Muhamad, R., & Mohamed, W. M. I. W. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01577-6 · Cited by 5
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management
Goldman, J. D., Triplitt, C. L., & Isaacs, D. M. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241287790 · Cited by 8

Authors: Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐.
Affiliations: Johns Hopkins University (US)
Heart of England NHS Foundation Trust (GB)
University of Miami (US)
München Klinik Bogenhausen (DE)
Corresponding author: Peyrot, M.
ORCID: Peyrot, M.
Meneghini, L. F.
Venue: Diabetic Medicine
Publisher: Wiley
Published: 2012-04-16
Volume: 29
Issue: 5
Pages: 682-689
ISSN: 0742-3071 (ISSN-L)
1464-5491
DOI: 10.1111/j.1464-5491.2012.03605.x
PMC: PMC3433794
OpenAlex: W1613501644
Cited by: 655
References: 22
Citations by year: 2026: 29 · 2025: 41 · 2024: 61 · 2023: 43 · 2022: 42 · 2021: 43 · 2020: 53 · 2019: 49 · 2018: 52 · 2017: 48 · 2016: 52 · 2015: 50 · 2014: 46 · 2013: 35 · 2012: 8
FWCI: 38.62
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Diabetic Medicine (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics: Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: insulin therapy, insulin adherence, insulin omission, barriers to adherence, patient beliefs, physician beliefs, type 1 diabetes, type 2 diabetes, glycemic control, hypoglycemia, basal insulin, prandial insulin, insulin dose adjustment
MeSH terms: Assessment of Medication Adherence, Blood Glucose, China, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, France, Germany, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Japan, Male, Middle Aged, Spain, Turkey, United States, Health Behavior, Drug Monitoring, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks